New and Generic Drug Approvals from FDA

Apr 16 2004
New and Generic Drug Approvals

Related Stories

  • Apidra (insulin glulisine [rDNA origin]) Injection, Aventis Pharmaceutal Inc.
  • Diazepam Injection, Parenta Pharmaceuticals
  • Dopram (doxapram hydrochloride) Injection, Baxter Healthcare
  • Fosamax (alendronate sodium) Tablets & Oral Solution, Merck
  • Intralipid I.V. Fat Emulsion, Fresenius Kabi
  • Mylotarg (Gemtuzumab Ozogamicin) Injection, Wyeth Pharmaceuticals
  • Thallous Chloride TI-201 Injection USP, Mallinckrodt Inc.
  • Zelnorm (tegaserod maleate) Tablets, Novartis Pharmaceuticals Corporation

Posted in: Pharmaceutical News

Tags: , , , , , ,

Comments (0)

Suggested Reading

Music can trigger cells to release insulin within minutes
Closed-loop system appears to be safe and superior to usual care in controlling glucose in children with type 1 diabetes
Study reveals contrasting effects of sucralose on insulin and glucose control
Gut microbes play a starring role in insulin resistance, opening doors for new diabetes treatments
Wait, What’s a PBM?
Adiponectin can be a potential therapeutic target for obesity and diabetes
Inflation Reduction Act's $35 insulin cap linked to rise in prescription fills
A type of gut bacteria may protect against the development of obesity and type-2 diabetes

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »
You might also like...
Theabrownin from dark tea may have the potential to treat insulin resistance